Recursion Pharmaceuticals, Inc.
RXRX
$3.39
-$0.03-0.88%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.06% | 54.29% | 10.70% | 68.89% | 51.79% |
| Total Receivables | -49.87% | 871.62% | 755.34% | 1,674.68% | 1,489.08% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -60.33% | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -19.42% | -26.91% | -11.13% | -21.46% | -5.35% |
| Total Current Assets | 13.80% | 50.60% | 12.40% | 70.00% | 63.02% |
|
|
|||||
| Total Current Assets | 13.80% | 50.60% | 12.40% | 70.00% | 63.02% |
| Net Property, Plant & Equipment | -27.33% | 13.85% | 23.88% | 67.55% | 94.06% |
| Long-term Investments | 8.92% | 211.28% | 215.56% | 203.73% | 185.99% |
| Goodwill | 8.92% | 211.28% | 215.56% | 203.73% | 185.99% |
| Total Other Intangibles | -7.73% | 845.48% | 793.27% | 915.21% | 821.59% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.37% | 120.22% | 67.25% | 161.66% | 137.85% |
| Total Assets | 1.76% | 92.64% | 67.86% | 133.98% | 121.60% |
|
|
|||||
| Total Accounts Payable | -16.17% | 516.59% | 413.40% | 390.44% | 446.75% |
| Total Accrued Expenses | -13.40% | 86.41% | 163.65% | 121.72% | 92.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.10% | 24.26% | 22.54% | 234.15% | 260.89% |
| Total Finance Division Other Current Liabilities | -39.54% | -5.63% | 20.82% | 9.20% | 53.42% |
| Total Other Current Liabilities | -39.54% | -5.63% | 20.82% | 9.20% | 53.42% |
| Total Current Liabilities | -21.21% | 42.44% | 90.54% | 92.07% | 101.21% |
|
|
|||||
| Total Current Liabilities | -21.21% | 42.44% | 90.54% | 92.07% | 101.21% |
| Long-Term Debt | -71.78% | 1,072.61% | -- | 1,435.57% | -37.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -34.55% | -31.62% | -27.02% | 27.95% | 97.14% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.52% | 617.97% | 371.24% | 313.61% | 166.41% |
| Total Liabilities | -17.05% | 74.60% | 100.20% | 136.95% | 117.50% |
|
|
|||||
| Common Stock & APIC | 28.15% | 67.75% | 54.00% | 74.88% | 72.86% |
| Retained Earnings | -45.04% | -57.13% | -56.12% | -54.27% | -47.92% |
| Treasury Stock & Other | 580.78% | -- | -- | -- | -- |
| Total Common Equity | 9.29% | 99.59% | 57.27% | 132.82% | 123.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.29% | 99.59% | 57.27% | 132.82% | 123.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.29% | 99.59% | 57.27% | 132.82% | 123.28% |
|
|
|||||